📰 Genentech News
Page 137 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
July 7, 2023
A key developmental step in the lifecycle of the most virulent species of malaria parasite depends in part on a series of molecular signals, detailed in a new study led by researchers at Weill Cornell Medicine. The findings may help scientists develo
July 7, 2023
News, features, and commentary about cancer-related issues
July 7, 2023
LEXINGTON - Curis, Inc., , a biotechnology company focused on the development of emavusertib, an orally available small molecule triple target inhibitor for the treatment of hematologic...
July 6, 2023
/PRNewswire/ -- Curis, Inc., (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib, an orally available small molecule triple...
July 6, 2023
/PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that its lead...
July 6, 2023
/PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of emavusertib, a triple target inhibitor (IRAK4, FLT3 and CLK)...
July 6, 2023
/PRNewswire/ -- DelveInsights Esophageal Cancer Market Insights report includes a comprehensive understanding of current treatment practices, esophageal...
July 5, 2023
Dr. Juliana Biondo discusses what the future of treatment for hemophilia A looks like based on ongoing trials.
July 5, 2023
Erica Taylor VP, CMO, Genentech spoke with Insider about why first-person stories matter in the healthcare, at the Cannes Lions International Festival of…
July 5, 2023
In 2023, several breakthroughs have shaken the academic community. Freezing entire organs to sub-zero temperatures for future transplantation is now a reality.